Leo Qian

Leo Qian has a diverse work experience in the field of research and biotechnology. Leo co-founded and held the position of Vice President and Co-founder of Discovery Research at Entrada Therapeutics, a biotechnology company focusing on intracellular delivery of biologics for the treatment of severe diseases. Leo Qian has been associated with Entrada Therapeutics since 2016. Prior to that, they worked as a Research Scientist at The Ohio State University from August 2014 to May 2018. Leo also worked as a Graduate Research Associate at the same university from September 2009 to August 2014.

Leo Qian earned a Ph.D. in Organic Chemistry from The Ohio State University, where they studied from 2009 to 2014.